Log In
Print this Print this

bisantrene (UPI-928)

  Manage Alerts
Collapse Summary General Information
Company Race Oncology Ltd.
DescriptionSmall molecule anthracene derivative
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAcute myelogenous leukemia (AML)
Indication DetailsTreat acute myelogenous leukemia (AML)
Regulatory Designation U.S. - Orphan Drug (Treat acute myelogenous leukemia (AML))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today